News
Contact Us
Support

Home
Our Philosophy
OVITEX
Investors

Press Releases
Events & Presentations

News Releases

News Releases

Year

Jun 14, 2021

TELA Bio to Participate in Upcoming JMP Securities Life Sciences Conference

Jun 02, 2021

TELA Bio Announces Changes to its Board of Directors

May 25, 2021

TELA Bio Names Marissa Conrad as Vice President of Clinical and Regulatory Affairs

May 21, 2021

TELA Bio to Participate in Upcoming Investor Conferences

May 19, 2021

TELA Bio Initiates BRAVO II Study of OviTex® for the Robotic Repair of Ventral Hernias

May 13, 2021

TELA Bio Announces First Quarter 2021 Financial Results

Apr 29, 2021

TELA Bio to Announce First Quarter 2021 Financial Results

Mar 24, 2021

TELA Bio Announces Fourth Quarter and Full Year 2020 Financial Results

Mar 18, 2021

TELA Bio Announces 12-Month Analysis from BRAVO Study of OviTex® for Ventral Hernia Repair

Mar 02, 2021

TELA Bio to Report Fourth Quarter and Full Year 2020 Financial Results on March 24, 2021

Pagination

Current page 1
Page 2
Next page
Last page

Print Page

RSS Feeds

Email Alerts

Contact IR

Privacy Policy
Legal
Contact Us

Linkedin
Facebook
Twitter
Instagram

©2021 TELA Bio, Inc. All Rights reserved.